The parent company to Patientrack - which provides technology to NHS hospitals to alert staff when patients are at risk of harm - has entered into a reseller agreement withhealthcare software provider Better by Marand tohelp hospitals tackle medication errors. 
Coordinate My Care has publicly launched its new service, myCMC, powered by InterSystems HealthShare, which enables patients in London to create their own urgent care plans and share them with health professionals. 
At the ISMRM (International Society for Magnetic Resonance in Medicine) in Montreal, Canada, Siemens Healthineers is the first supplier in the world to offer magnetic resonance fingerprinting (MRF) as a product for tissue analysis in clinical neurological research. 
Royal Philips (NYSE: PHG, AEX: PHIA) today announced a collaboration with Medtronic to further advance treatment of paroxysmal atrial fibrillation (PAF), a common heart rhythm disorder. Through the agreement, Medtronic will facilitate sales of products on behalf of Philips to provide an innovative, integrated image guidance solution for cryoablation procedures. Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced that telehealth service provider Chipmunk Health, with locations in the Netherlands and Canada, is leveraging the capabilities and services of Philips' HealthSuite digital platform to roll out its new GP-to-patient home monitoring solutions. 
Sensyne Health plc (LSE: SENS), the British clinical AI technology company, and Bayer, the life sciences company, announce that Bayer has become Sensyne Health's preferred pharmaceutical partner to work together on the development of a national linked patient data capability. Bayer joins Microsoft, EY, JP Morgan, and Peel Hunt in this consortium. 
AstraZeneca and BenevolentAI began a long-term collaboration to use artificial intelligence (AI) and machine learning for the discovery and development of new treatments for chronic kidney disease (CKD) and idiopathic pulmonary fibrosis (IPF).